Navigation Links
Sun Pharma Announces Expiration of Subsequent Offering Period
Date:9/29/2010

MUMBAI, India, Sept. 29 /PRNewswire/ -- Sun Pharmaceutical Industries Ltd. (Sun) (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) today announced the expiration of the subsequent offering period to the tender offer by Sun's subsidiary Alkaloida Chemical Company Exclusive Group Ltd (Alkaloida) for all outstanding Ordinary Shares of Taro Pharmaceutical Industries Ltd. (Taro). Sun has been informed by Computershare, the Depositary for the Offer, that as of 12:00 midnight New York City time on September 28, 2010, a total of 29,382 Ordinary Shares had been tendered pursuant to the tender offer representing approximately 0.07% of the outstanding Ordinary Shares.  During the pendency of the subsequent offering period, no additional shares have been tendered.  All tendered Ordinary Shares were accepted for payment.

About Sun PharmaEstablished in 1983, listed since 1994 and headquartered in India, Sun Pharma (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) is an international, integrated, speciality pharmaceutical company.  It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India, US and several other markets across the world.  In India, the company is a leader in niche therapy areas of psychiatry, neurology, cardiology, diabetology, gastroenterology, orthopedics and ophthalmology.  The company has strong skills in product development, process chemistry, and manufacturing of complex API, as well as dosage forms. More information about the company can be found at www.sunpharma.com.

ContactsUday Baldota

Mira DesaiTel

+91 22 6645 5645, Xtn 605Tel

+91 22 6645 5645, Xtn 606Tel Direct

+91 22 66455605Tel Direct

+91 22 66455606Mobile

+91 98670 10529Mobile

+91 98219 23797E mail

uday.baldota@s
'/>"/>

SOURCE Sun Pharmaceutical Industries Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
8. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
9. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
10. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
11. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... and NEW YORK ... As the leading distributor of market intelligence, ... new research report by IQ4I Research and Consultancy focusing ... To learn more about IQ4I Research visit: ... Active Pharmaceutical Ingredients Global Market – Forecast to ...
(Date:11/26/2014)... 25, 2014  At the American Dental Association,s Annual ... October, KaVo Kerr Group was honored to be part ... the opportunity to see and test the Best of ... deliver lectures on the latest developments in dental technology. ... new DEXIS CariVu Caries Detection Device and Kerr Demi ...
(Date:11/26/2014)... ANDOVER, Mass. , Nov. 25, 2014 ... Royal Philips (NYSE: PHG ... Food and Drug Administration (FDA) for its IQon ... spectral imaging. This first-of-its kind technology adds a new ... and offering the ability to characterize structures based on ...
Breaking Medicine Technology:MarketResearch.com: Active Pharmaceutical Ingredient Market to Reach $175 Billion by 2020 Says IQ4I Report 2MarketResearch.com: Active Pharmaceutical Ingredient Market to Reach $175 Billion by 2020 Says IQ4I Report 3KaVo Kerr Group Showcased in Pride Institute Technology Expo at ADA Annual Meeting 2KaVo Kerr Group Showcased in Pride Institute Technology Expo at ADA Annual Meeting 3Philips receives FDA 510(k) clearance for IQon Spectral CT 2Philips receives FDA 510(k) clearance for IQon Spectral CT 3
... China, July 21, 2011 /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited ... marketer of medical devices worldwide, today announced that it will ... 30, 2011 after the U.S. market closes on August 8, ... 8:00 AM on August 9, 2011 U.S. Eastern Time (8:00 ...
... 21, 2011 Mettler-Toledo International Inc. (NYSE: MTD ... discuss the Company,s second-quarter results on Thursday, July 28, 2011 ... of the call, visit www.mt.com/investors on the Company,s ... August 1, 2011. METTLER TOLEDO is a ...
Cached Medicine Technology:Mindray to Report Second Quarter 2011 Financial Results on August 8, 2011 2
(Date:11/27/2014)... In addition to a new dessert recipe ... this holiday season and become educated about the warning ... over the holidays may raise questions about the physical ... in cognitive ability can occur with age, serious memory ... the difference between normal aging and more serious problems ...
(Date:11/26/2014)... Angeles, CA (PRWEB) November 26, 2014 ... to treat themselves this holiday season! With Parsa Mohebi ... incredible 10% off of their next FUE procedure, making ... transplant. , FUE—which stands for “Follicular Unit Extraction”—is an ... advantages over traditional “strip” Follicular Unit Transplantation (FUT). FUE, ...
(Date:11/26/2014)... 2014 Boxing Day is traditionally the ... receive gifts, known as a "Christmas box", from their ... With the coming of Boxing Day, some people may ... before every business opportunity, and it has recently announced ... site-wide promotion for its global customers. Then people can ...
(Date:11/26/2014)... Dallas, Texas (PRWEB) November 26, 2014 ... surgeon and Distinguished Teaching Professor in the ... Center, recently discussed facial fat compartments, fat grafting, ... Surgery, The Meeting," an annual conference held by ... importance and intricacies of this underlying facial structure ...
(Date:11/26/2014)... HealthDay Reporter WEDNESDAY, Nov. 26, 2014 ... understand what they,re saying, a new study suggests they are ... way. Past research has shown that dogs respond to ... and the emotional tone, said study author Victoria Ratcliffe. ... canine brain, according to Ratcliffe, a Ph.D. candidate at the ...
Breaking Medicine News(10 mins):Health News:Alzheimer's Association Shares Tips to Navigate the Holiday Season 2Health News:Alzheimer's Association Shares Tips to Navigate the Holiday Season 3Health News:Alzheimer's Association Shares Tips to Navigate the Holiday Season 4Health News:Alzheimer's Association Shares Tips to Navigate the Holiday Season 5Health News:FUE Special at Parsa Mohebi Hair Restoration This Holiday Season 2Health News:Tbdress.com: Best Boxing Day Sales For Ladies Worldwide 2Health News:Dr. Rod J. Rohrich Discusses Facelifts at ASPS Annual Assembly 2Health News:Dr. Rod J. Rohrich Discusses Facelifts at ASPS Annual Assembly 3Health News:Your Dog Really Is Listening to You 2Health News:Your Dog Really Is Listening to You 3
... of patients who contracted Hepatitis C in the 1980s had ... condition.// This is same as delayed is denied. ... McGuire, after studying documents obtained through the Freedom of Information ... and advise patients and that some had infected their partners. ...
... England is at its lowest ever with 8.5 deaths per 100,000 ... also noted that for the first time in 25 years there ... committing suicide. ,The British government had pledged to cut ... in 2002. The current report was jointly issued by the Department ...
... inflammation. According to a German clinical trail conducted by ... found that high doses of Vitamin D supplements inhibit ... function. The results of the study were published in ... researchers studied the effect of a high-dose vitamin D3 ...
... experts about the hearing loss caused by the MP3 ... without paying// any heed to those warnings. But sensing ... started limiting the volume on the devices. ,The ... damage to the ears associated with MP3 players. The ...
... to avoid controversial breast enlargement gel injections after six ... ,Fifty-three women from Hong Kong have complained of ... gel injected into their breasts. ,Six women ... after suffering severe complications from the operation, a spokesman ...
... an outbreak of malaria that claimed 35 lives and affected ... across Assam and medical teams are working on a war ... Bhumidhar Barman told IANS. ,Most of the casualties ... Lakhimpur, besides from areas bordering Bhutan. ,"Some 35 ...
Cached Medicine News:Health News:High Dose Of Vitamin D3 A Boon for Patients Suffering From Heart Failure 2Health News:Sensing The Health Hazard MP3 Makers Tone Down The Volume 2Health News:Malaria Claims 35 Lives In Assam 2
Jaffe tying forceps is very delicate with smooth jaws, straight, 6 mm long platform. For 8-0 to 11-0 sutures....
Curved shafts and tips with tying surfaces. Wide serrated handle with dull finish. Overall length 4.3 inches....
Curved shafts and tips with 7 mm tying platform. Serrated handle with polished finish. Overall length 4 inches....
Straight shafts with 5 mm tying platform. Wide handle with dull finish. Overall length 4.3 inches....
Medicine Products: